[1]
A. Mohamed Sikkander, C. Hazarathaiah Yadav, and Narendra Revanuri, Trans., “A 2025 meta-analysis in non–small-cell lung cancer (NSCLC) indicates glucocorticoid administration is significantly associated with worse progression-free survival (PFS) and overall survival (OS) for patients on ICIs”, WJAMS, vol. 2, no. 11, pp. 1–3, Nov. 2025, doi: 10.65336/WJAMS.2025.21101.